Sanofi’s and Regeneron’s Dupixent wins new stage of EU regulatory approval
The companies announced today that the EU approval is indicated for treating children as young as 6 months old with severe atopic dermatitis.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Precision Value & Health Names Doug Fulling President
/in Marketing & AdvertisingAs the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Fulling will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise.
EU regulator accepts for review Alzheimer’s treatment from Eisai-Biogen
/in TherapeuticsThe application to the EMA was based on results from a late-stage study that showed the drug slowed down the rate of cognitive decline in patients with early Alzheimer’s by 27%, compared with a placebo.
U.S. FDA pulls authorization for AstraZeneca’s COVID-19 treatment Evusheld
/in TherapeuticsThe treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of Omicron.
U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
/in TherapeuticsCannabis products, excluding Jazz Pharmaceuticals Plc’s epilepsy drug Epidiolex, are illegal at the federal level in the United States, although some states allow their use.
Taking oncology therapies to market requires change in commercialization models
/in February 2023, Issue Archives, Marketing & AdvertisingAs the healthcare journey for patients living with cancer has changed, so has the way in which pharmaceutical companies bring a drug to market. Med Ad News spoke with Anne Marie Robertson, SVP, strategy & marketing, EVERSANA about how companies need to rethink traditional commercialization models in oncology to be agile in today’s market.
EU drug regulator decides ongoing antibiotic shortage not a ‘major event’- source
/in TherapeuticsAlthough nearly all the countries in Europe are reporting shortages, the EMA is not going to label the ongoing shortage of antibiotics in the continent a “major event”, according to a source familiar with the matter.
Patient death pauses another AML trial
/in TherapeuticsFollowing the death of a patient, Magenta Therapeutics placed a hold on Phase I/II dose-escalation trial of its acute myeloid leukemia therapy.
Walgreens weighs $2 bln sale of pharmacy automation unit – Bloomberg News
/in TherapeuticsWalgreens will prepare for the start of Automation Unit iA’s sale process around next month, according to Bloomberg, which cited sources who asked not to be identified as the matter is private.
Eduardo Tavares joins dentsu health as executive creative director
/in Marketing & AdvertisingDentsu today announced the appointment of Eduardo Tavares as Executive Creative Director, dentsu health. In this role, multi-award winner Tavares, will concept and deliver best-in-class creative campaigns – merging data and technology with craft – to drive value and competitive advantage for dentsu health clients across health & wellness and pharmaceutical sectors.